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We explore the anti-microbial activity of urine specimens after the ingestion of a commercial
cranberry preparation. Twenty subjects without urinary infection, off antibiotics and all
supplements or vitamins were recruited. The study was conducted in two phases: in phase 1,
subjects collected the first morning urine prior to ingesting 900mg of cranberry and then at 2, 4
and 6h. In phase 2, subjects collected urine on 2 consecutive days: on Day 1 no cranberry was
ingested (control specimens), on Day 2, cranberry was ingested. The pH of all urine specimens
were adjusted to the same pH as that of the first morning urine specimen. Aliquots of each
specimen were independently inoculated with Escherichia coli, Klebsiella pneumoniae or Candida
albicans. After incubation, colony forming units/ml (CFU ml
1) in the control specimen
was compared with CFU ml
1 in specimens collected 2, 4 and 6h later. Specimens showing
50% reduction in CFU ml
1 were considered as having ‘activity’ against the strains tested.
In phase 1, 7/20 (35%) subjects had anti-microbial activity against E. coli, 13/20 (65%) against
K. pneumoniae and 9/20 (45%) against C. albicans in specimens collected 2–6h after ingestion of
cranberry. In phase 2, 6/9 (67%) of the subjects had activity against K. pneumoniae. This pilot
study demonstrates weak anti-microbial activity in urine specimens after ingestion of a single
dose of commercial cranberry. Anti-microbial activity was noted only against K. pneumoniae
2–6h after ingestion of the cranberry preparation.
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Background
Cranberry (Vaccinium macrocarpon) fruits and leaves
have a long history of traditional use in folk medicine for
the management of diverse conditions including urinary
problems, wounds, stomach problems, diabetes, etc. Over
the last decades popular interest in the use of cranberry
for the prevention and treatment of urinary tract
infections (UTI) has been on the rise. Sales of cranberry
in 2005 exceeded $15 million and cranberry was ranked
the fifth highest selling herb in the US (1).
Scientific interest in cranberry followed popular
interest closely. A PubMed search over the last 36 years
(1970–2006), limited to title, identified 185 papers on
cranberry, of which, 22 were randomized controlled trials,
and two Cochrane reviews. The majority of published
controlled trials explore the effectiveness of cranberry for
the prevention of UTI (2). Cochrane reviewers concluded
that evidence from two well-designed studies indicates that
cranberry juice decreased the number of symptomatic
UTIs over a 12-month period. Few studies looked at
the use of cranberry for the treatment of UTI, however
well-designed studies are yet to be conducted as indicated
by the 2004 Cochrane review (3). No major adverse effects
or interactions were reported or identified in these reviews
or more recent studies (4,5).
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properly cited.With mounting interest in the clinical use of cranberry,
scientific curiosity about cranberry’s anti-microbial
mechanism of action grew. The exact anti-microbial
action of cranberry remains under investigation. Initial
proposed mechanism attributed the anti-microbial bene-
fits to hippuric acid which has the potential to acidify the
urine (6). Later studies confirmed that cranberry juice can
lower urinary PH (7,8). More recently, studies suggested
that cranberry’s activity is related to the inhibition of
bacterial adherence to the uroepithelium. Recent evidence
suggests that fructose, found in cranberries, interferes
with adhesion of type 1 fimbriated (mannose-sensitive)
Escherichia coli to the uroepithelium (9), while other
studies show that proanthocyanidins in cranberries
inhibit the adherence of p-fimbriated (mannose-resistant)
E. coli to the uroepithelium (10,11). In fact, recent
studies suggest that cranberry juice irreversibly inhibits
p-fimbriae preventing attachment of E. coli to the
uroepithelium (12).
In addition to the anti-adhesive effect, a possible anti-
microbial activity has been suggested. In effect a
laboratory study verified that concentrated cranberry
juice had a direct anti-microbial activity in vitro (13).
However, despite the encouraging outcomes reported in
the prevention studies and in laboratory studies looking
at mechanism of action, evidence of direct anti-microbial
activity in the urine after ingestion of cranberry has yet to
be demonstrated.
To evaluate the anti-microbial effect of urine specimens
after ingestion of cranberry we conducted a pilot study
assaying the direct anti-microbial activity of urine speci-
mens taken from volunteer subjects after ingestion of a
commercially available cranberry product.
Methods
This study proposes to evaluate the in vitro bioactivity
(anti-microbial) of urine samples after ingestion of
cranberry. The protocols were approved by the institu-
tional review board. Twenty asymptomatic adults were
recruited for the entire study, all of them completed
phase 1, and nine completed phase 2. The study team was
blinded to the identity of the subjects. All subjects were
asked to abstain from taking any cranberry, health food
fruit extracts, anti-oxidants, vitamins or minerals and
antibiotics for 1 and 2 weeks, respectively, prior to
particpating in the studies and during specimen collec-
tion. Subjects were also asked to complete a food diary
starting 3 days prior and on the day(s) of specimen
collections.
Product Used
A commercially available cranberry softgel ‘TruNature’
was used in this study. Each 300mg softgel contained of
a mixture of dry whole cranberry extract (275mg) and
ShanStar Concentrate cranberry extract (25mg).
ShanStar Concentrate extract is a highly purified
preparation of cranberry proanthocyanins on cross-
linked polyvinylpyrrolidone (PVP) substrate. During the
preparation, PVP is mixed into normal cranberry juice.
The proanthocyanins and other polyphenolic compounds
have a very high affinity for the PVP molecule. The PVP-
cranberry (CB-PVP) is then removed from the juice by
filtration and dried. HPLC analysis of ShanStar
Concentrate extract shows several 100-fold increase in
the concentration of the proanthocyanins and other
polyphenolic compounds when compared to normal
juice without the high level of sugars and organic acids
usually found in cranberry juice (14). To ensure that the
activity seen in the test is from cranberry and not from
PVP, we conducted a small comparison of the anti-
bacterial activity of PVP versus cranberry PVP (Table 1).
The results confirm that the anti-bacterial activity seen is
from cranberry.
Study Conducted
The study was conducted in two phases. In the phase 1,
urine was collected for 1day only. On the day of the
study, the first morning urine was collected as a baseline
contol urine. Subjects were then asked to take a
commercial cranberry product (TruNature cranberry
300mg softgels). Each subject was asked to take three
Table 1. Anti-bacterial activity of cranberry PVP versus PVP in Broth
Strains CB PVP Broth only PVP broth Cranberry PVP broth
Batch No. CFUml
1 Dilution CFU ml
1 Dilution CFUml
1
E. coli (ATTC 295220) 1 210
9 1:2 1.710
8 1:2 110
7
2 3.710
8 1:2 910
7 1:2 510
6
3 1.910
9 1:2 1.810
8 1:2 110
7
K. pneumonia (ATCC 13883) 4 4.310
8 1:2 8.510
7 1:2 <10
2
S. aureus (ATCC 29213) 4 110
8 1:2 1.810
8 1:2 1.610
1
Proteus mirablis (Clinical isolate) 4 1.910
8 1:2 7.210
7 1:2 2.610
4
Initial inoculate approximately 10
5 CFUml
1. Overnight incubation at 35C.
228 Anti-microbial activity of cranberrysoftgels (900mg) once in the morning. Additional urine
samples were then collected at 2h inetrvals over 6h, for a
total of three samples (at 2, 4 and 6h post-ingestion of
cranberry) (Fig. 1). Each subject was asked to immedi-
ately refrigerate all samples after testing and recording
each specimens’ specific gravity and PH. All specimes and
data were confidentially coded. Thirteen subjects were
enrolled in this phase of the study.
In phase 2, the protocol was amended and subjects
were asked to collect urine specimens for two subsequent
days. On Day 1, urine was collected at 2h intervals, as in
phase 1, but without cranberry ingestion (control speci-
mens). On Day 2, the protocol remained the same as that
of phase 1, (i.e. urine was collected at 2h intervals, as in
phase 1, but with cranberry ingestion, see Fig. 1). Thus,
in this phase of the study we were able to compare the
anti-microbial activity in urine samples collected on 2
subsequent days with and without ingestion of cranberry.
Nine subjects were tested; two subjects were already
enrolled in phase 1 of the study and consented to repeat
the sample collections for phase 2.
Microbiological Assays
In the laboratory, urines were filter-sterilized, aliquots of
each of the specimens was then assayed for anti-microbial
activity in vitro against a variety of common bacterial
organisms which can be the cause of human UTI.
The pH of all urine specimens was adjusted to the same
pH as the baseline control specimens and filtered.
Aliquots of each specimen were independently inoculated
with 10
2–10
3 cell ml
1 each of single strains of E. coli,
Klebsiella pneumoniae and Candida albicans. Bacterial
strains tested included E. coli ATCC 29522,
K. pneumoniae ATCC 13883 and clinical strain C.
albicans from University of California at Irvine medical
center. Overnight cultures were incubated at 35Co n
tryticase soy agar media were used as inocula.
A low inoculum of bacteria was used deliberately
to mimic colonization and not an established infection.
The organisms were the same strains utilized in our
pilot study (13). After 24h of incubation for E. coli and
K. pneumoniae, and 48h for C. albicans, colony forming
units per milliliter (CFU ml
1) of each specimen were
enumerated by subculture with quantitative plate counts
in duplicate. The number of CFU ml
1 in the baseline
control specimens (early morning urine specimen) were
compared with CFU ml
1 in specimens collected 2, 4 and
6h after ingestion of cranberry. Specimens that showed
50% reduction in CFU ml
1 compared with its controls
were considered as having ‘activity’ against the strains
tested.
Data Analysis
Data was analyzed in two parts: in part one data from all
20 subjects were included comparing the anti-microbial
activity of samples 2, 3 and 4 (all after ingestion of
cranberry) to the morning urine sample (control specimen
taken before ingestion of cranberry). In part two, nine
subjects who collected samples as per phase 2 protocol
(2-day urine collection) were included. Morning urine
specimens were used as the controls in each of the 2 days
of this phase. Anti-microbial activity at 2, 4 and 6h were
compared with the morning specimen (as control) of their
respective day. Presence of anti-microbial activity was
defined as 50% reduction in CFU ml
1 between the first
morning urine specimen (control) and subsequent speci-
mens collected at 2, 4 and 6h. The statistic method used
was McNemar chi-squared test.
Results
Phase 1
Data from all 20 subjects were initially analyzed
comparing morning urine anti-microbial activity to that
seen after ingestion of cranberry. Four men and 16
women age range 36–72 years, provided urine specimens.
Anti-microbial activity (50% reduction in CFU from
control specimen) against E. coli strain was identified in 7
of the 20 (35%) subjects studied. Anti-microbial activity
was also seen in 13/20 subjects (65%) for K. pneumoniae
strain and in 9/20 (45%) for C. albicans. Timing of the
observed activity varied and was seen at 2, 4 or 6h:
however, most activities were noted 2h after ingestion of
cranberry (Fig. 2). The activity was generally modest but
ranged from <1 log10 (50%) reduction to 2 log10 (99%)
reduction in CFU.
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Figure 1. Time line for urine collection.
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In the second phase of the study, nine subjects provided
urine specimens, seven women and two men. Analysis of
specimens provided during the second phase of the study
showed no significant difference in anti-microbial activity
between control (Day 1 without cranberry) and test
(Day 2 with cranberry) urine specimens for E. coli and
C. albicans. Anti-microbial activity against K. pneumoniae
was noted in six out of nine subjects (67%) on day 2 after
cranberry ingestion compared to 2/9 (22%) on day 1 (no
cranberry) (Fig. 3). Due to the small sample size, the
difference was not statistically significant.
No difference in activity between men and women was
noted, although the number of men sampled was too
small for adequate comparison. Selection of study
volunteers was not stratified by age group. None of the
enrolled subjects withdrew prior to completing the study.
No side effects were reported throughout the study.
Discussion
Cranberry is commonly recommended for treatment/
prevention of UTIs. Cochrane reviews of clinical studies
concluded that evidence supports a role for cranberry in
the prevention of UTIs, but not in the treatment of
an established infection (3,15). Proposed mechanisms
of action included anti-adherance (9–12,16,17), anti-
bacterial (13), changes in urine acidity (PH) (7,8) and
activation of the nitric oxide pathway. Laboratory studies
identified a direct anti-bacterial activity of cranberry (13),
however little is known whether this activity is main-
tained after ingestion. In this study, we explored the
presence of anti-microbial activity in the urine of subjects
after ingestion of cranberry.
For this study, we used an inoculation of 10
2–10
3
instead of the standard 10
5. This decision was reached
after careful review of the published data and the
Cochrane reviews which concluded that cranberry was
more effective in the prevention (eliminate colonization)
rather than treatment of UTI.
We postulated that the anti-bacterial effect is due to the
anthocyanins and proanthocyanidins fractions of cran-
berry. Urine samples were collected at 2, 4 and 6h after
ingestion of cranberry. A recent study by Ohnishi et al.
(18) demonstrated the urinary levels of anthocyanins
reached a maximum between 3 and 6h after ingestion of
cranberry.
Our study suggests that anti-bacterial activity against
E. coli after ingestion of cranberry was not significant.
This confirms findings from two recent published studies
exploring the anti-bacterial activity of urine after inges-
tion of cranberry (14,19). Both studies adjusted the
specimens for urine PH. In the study by Monroy-Torres
et al. (14), 20 young (19–24 years old) healthy women
provided urine samples before and 3h after taking
250ml of cranberry juice. Urine samples were incubated
for 1–2h only then plated. No significant drop in the
number of E. coli colonies were seen. In the study by
Tong et al., 10 young healthy Chinese adults (mean age
20.41.2 years) collected urine at 3h intervals on 2
consecutive days. On day 2 subjects drank 750ml of
cranberry juice. Urine samples were inoculated with
2.810
7 E. coli and incubated for 24h. No statistically
significant differences were observed between the control
(day 1) and urine specimens collected on day 2 after
ingestion of the cranberry juice (19). Even though the
studies used different forms (juice and tablets) and doses
of cranberry, the final result was the same regardless of
the time of urine collection after cranberry ingestion.
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Figure 2. Anti-microbial activity found in urine after ingestion of cranberry compared with first morning urine (phase 1). Only maximal anti-
microbial activity identified for each participant is reported.
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microbial activity against less common causes of UTI,
such as C. albicans and K. pneumonia. No significant
drop in the number of colonies was observed for Candida
after ingestion of cranberry. However, anti-microbial
activity against K. pneumonia was detected in the urine
of six out of nine subjects after ingestion of the cranberry
capsules. It is of interest that the occurrence of anti-
microbial activity against K. pneumonia was noted when
samples were compared in phase 1 of the study (using
first morning urine specimen as control), and phase 2
(comparing samples from both days to their respective
morning control specimen). Timing of the observed
activity in all three strains tested varied among the 2, 4
or 6h specimens; however, activity was mainly observed
in the urine specimens collected 2h after ingestion of
the capsules. Based on this result one can postulate that
the anti-microbial activity found in this study against
K. pneumoniae is probably due to factors other than the
anti-adherence activity reported for E. coli.
During phase 1, 35%, 45% and 65% of specimens
collected form the 20 study subjects showed anti-microbial
activity in the urine against E. coli, C. albicans and
K. pneumoniae respectively. This activity occurred 2–6h
after ingestion of cranberry capsules. In the second phase,
23%, 33% and 67% of the specimens showed some
anti-microbial activity against E. coli, C. albicans and
K. pneumoniae respectively. It is of interest that the most
frequent occurrence of anti-microbial activity occurred in
both phases against K. pneumoniae. Thus, in the CB-PVP
there might be a different anti-microbial factor inhibiting
K. pneumoniae other than the anti-adherence factor
reported in previous studiers with E. coli.
We attempted to maximize the sensitivity of our essay by
using a low colony count and defining activity as a 50%
reduction in colony counts. We did this as we believe the
anti-microbial activity of natural products may be more
subtle than those noted in commercial antibiotics where a
two log reduction in colony count may be expected.
Further studies are warranted to better understand the
nature of the factors responsible for the anti-microbial
activity in urines following cranberry capsules ingestion, as
well as to better understand the bacterial spectrum of these
factors and how they might be enhanced including a
determination of optimal dosing. A study with higher con-
centration of CB-PVP and testing of bacterial adhesion is
in progress.
Conclusion
Following ingestion of cranberry, anti-microbial activity
was seen with K. pneumoniae. Additional studies are also
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Figure 3. Anti-microbial activity found in urine with and without ingestion of cranberry on 2 subsequent days (phase 2). Only maximal anti-
microbial activity identified per participant each day is reported.
eCAM 2010;7(2) 231needed to further explore the anti-microbial activity using
different formulations (juice, capsule) and doses. Other
studies should also explore the possibility of optimizing
the anti-microbial activity using cranberry in combination
with other fruits or supplements.
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